- March 19, 2026
Loading
A Bradenton company that develops advanced drug delivery technologies for complex and chronic diseases has made a strategic investment in a 3D-printed microneedle technology. Continuity Biosciences LLC did not disclose the amount it invested into PinPrint Inc.